1. Home
  2. APLS vs GBTG Comparison

APLS vs GBTG Comparison

Compare APLS & GBTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • GBTG
  • Stock Information
  • Founded
  • APLS 2009
  • GBTG 2014
  • Country
  • APLS United States
  • GBTG United States
  • Employees
  • APLS N/A
  • GBTG N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • GBTG Computer Software: Prepackaged Software
  • Sector
  • APLS Health Care
  • GBTG Technology
  • Exchange
  • APLS Nasdaq
  • GBTG Nasdaq
  • Market Cap
  • APLS 3.5B
  • GBTG 3.6B
  • IPO Year
  • APLS 2017
  • GBTG N/A
  • Fundamental
  • Price
  • APLS $25.17
  • GBTG $8.20
  • Analyst Decision
  • APLS Buy
  • GBTG Strong Buy
  • Analyst Count
  • APLS 20
  • GBTG 4
  • Target Price
  • APLS $34.11
  • GBTG $9.88
  • AVG Volume (30 Days)
  • APLS 2.1M
  • GBTG 909.1K
  • Earning Date
  • APLS 11-04-2025
  • GBTG 11-04-2025
  • Dividend Yield
  • APLS N/A
  • GBTG N/A
  • EPS Growth
  • APLS N/A
  • GBTG N/A
  • EPS
  • APLS N/A
  • GBTG N/A
  • Revenue
  • APLS $754,649,000.00
  • GBTG $2,440,000,000.00
  • Revenue This Year
  • APLS $20.59
  • GBTG $4.46
  • Revenue Next Year
  • APLS N/A
  • GBTG $4.58
  • P/E Ratio
  • APLS N/A
  • GBTG N/A
  • Revenue Growth
  • APLS 20.02
  • GBTG 3.61
  • 52 Week Low
  • APLS $16.10
  • GBTG $5.78
  • 52 Week High
  • APLS $39.51
  • GBTG $9.60
  • Technical
  • Relative Strength Index (RSI)
  • APLS 44.82
  • GBTG 60.41
  • Support Level
  • APLS $27.26
  • GBTG $7.80
  • Resistance Level
  • APLS $28.97
  • GBTG $8.33
  • Average True Range (ATR)
  • APLS 0.99
  • GBTG 0.19
  • MACD
  • APLS -0.58
  • GBTG -0.05
  • Stochastic Oscillator
  • APLS 11.00
  • GBTG 67.52

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

Share on Social Networks: